Memorial Sloan Kettering Cancer Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Memorial Sloan Kettering Cancer Center sits in the top decile of US sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count).
Memorial Sloan Kettering Cancer Center: 1,884 sponsored US clinical trials, 327 recruiting.
Memorial Sloan Kettering Cancer Center sponsors 1,884 registered US clinical trials on ClinicalTrials.gov, 327 of them currently recruiting, and 1,104 completed. 75 of these trials are in Phase 3-4 (later-stage) and 1,101 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 98 trials.
Top-decile sponsor footprint
Memorial Sloan Kettering Cancer Center ranks in the top decile of sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,884 total, page 4 of 38
A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
NCT06287528
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery
NCT06290193
A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer
NCT06251973
A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
NCT06123338
A Study of Pembrolizumab and Cryoablation in People With Breast Cancer
NCT06246968
A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma
NCT06192888
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
NCT06110793
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
NCT06144164
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer
NCT06130280
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
NCT06129903
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery
NCT06127979
A Study of Avutometinib for People With Solid Tumor Cancers
NCT06104488
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
NCT06099769
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
NCT06083922
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
NCT06066333
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
NCT06066346
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
NCT06058988
A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
NCT06057948
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
NCT06057935
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
NCT06055894
Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
NCT06037941
A Study of Mental Health Care in People With Cancer
NCT06037954
A Study of CRD3874-SI in People With Solid Tumors
NCT06021626
Using Urine Samples to Identify Lung Cancer
NCT06033248
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
NCT06017258
A Study of Blood Pressure Control During Cancer Treatment
NCT06023576
A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer
NCT06007937
A Study of Avutometinib and Defactinib in People With Thyroid Cancer
NCT06007924
A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma
NCT05764954
A Study of Stereotactic Radiosurgery (SRS) to Treat Pain in the Chest and/or Stomach Wall
NCT05985148
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
NCT05985161
A Registry for People With T-cell Lymphoma
NCT05978141
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
NCT05837767
Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation
NCT05873205
A Study of Changes in Heart Function and Blood Flow in People Receiving Anesthesia
NCT05954832
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
NCT05940272
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
NCT05756777
A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract
NCT05868265
A Study to Prevent and Improve Sexual Health Concerns for People With Breast Cancer
NCT05910294
Cord Blood Transplant in Adults With Blood Cancers
NCT05884333
A Study of the Use of Fat Flap Reconstruction to Reduce Neck Injury After Cancer Treatment
NCT05889091
A Study of NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC)
NCT05851924
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
NCT05859074
Empathic Communication Skills (ECS) Training
NCT05456841
A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers
NCT05789485
A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania
NCT05438511
A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer
NCT05787561
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
NCT05787574
A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
NCT05736419
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
NCT05733013
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 461 |
| Phase 2 | 640 |
| Phase 3 | 67 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Memorial Sloan Kettering Cancer Center pipeline
327 recruiting of 1,884 indexed (17% open); 1,104 completed (59%).
Phase mix: 75 late (III/IV) vs 1,101 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (98 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.